Skip to content

ICE-T Pain Regimen for Total Laparoscopic Hysterectomy

ICE-T Postoperative Multimodal Pain Regimen Compared to the Standard Regimen in Laparoscopic Gynecologic Surgery: a Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03987022
Enrollment
66
Registered
2019-06-14
Start date
2019-08-01
Completion date
2022-04-25
Last updated
2025-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Substitution Treatment

Keywords

Anti-inflammatory agents non-steroidal

Brief summary

The purpose of this randomized controlled trial is to determine whether, ICE-T, a multimodal postoperative pain regimen composed of around the clock ice packs, toradol, and tylenol, has improved pain control compared to the standard narcotic based postoperative pain regimen in patients undergoing total laparoscopic gyn surgery.

Detailed description

Laparoscopy is a frequently used route for hysterectomy. Yet few studies have investigated opioid-sparing postoperative regimens for this common surgery. The study objective was to determine whether ice packs, Tylenol, and Toradol (ICE-T), an opioid-sparing multimodal postoperative pain regimen, has improved pain control compared with a standard opioid-centric postoperative pain regimen in total laparoscopic hysterectomy patients. The study was a randomized controlled trial. It included total laparoscopic hysterectomy postoperative patients that were randomized to the ICE-T or standard regimen. The ICE-T regimen prescribed scheduled around-the-clock ice-packs, acetaminophen and ketorolac. The standard protocol prescribed as needed ibuprofen and acetaminophen/oxycodone based on pain score. Both regimens included intravenous hydromorphone for breakthrough pain. However, subjects in the ICE-T group who requested additional narcotic medications prior to postoperative day 4, were prescribed supplemental narcotics in addition to the ICE-T regimen. The subjects pain control and quality of recovery were assessed on postoperative day 1 and 4.

Interventions

DRUGKetorolac

Use of non-steroidal anti-inflammatory drug for pain control postoperatively

DRUGOpioids

Use of narcotic for pain control postoperatively

OTHERIce Packs

Placement of Ice packs on surgical sites postoperatively

Use of pain medication postoperatively

DRUGMotrin

Use of non-steroidal anti-inflammatory drug for pain control postoperatively

Use of narcotic for pain control postoperatively

Use of combination tablet of Tylenol and Oxycodone for pain control postoperatively

Sponsors

MetroHealth Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Masking description

The randomized sequence was masked to all except the statistician who developed the sequence. Upon randomization, the participants, care providers, investigators and outcome assessors were aware of the participant study arm allocations.

Intervention model description

Enrolled patients were randomized at the end of surgery using sequentially numbered opaque sealed envelopes. A statistician developed the 1:1 mixed block randomization sequence using a random number generator; only the statistician was aware of the sequence. They were randomized to 1 of 2 postoperative pain regimens: ICE-T opioid-sparing regimen or the Standard opioid-centric regimen. The pain regimen protocols began upon PACU discharge. Subjects received their regimens as assigned, except that patients assigned to the ICE-T opioid-sparing group who requested additional narcotic medications prior to postoperative day 4 were prescribed supplemental opioids in addition to their ICE-T regimen medications.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

The inclusion criteria are the following: * Consenting, English speaking women between ages 18 and 80 who will undergo same day laparoscopic gyn surgery at MetroHealth Medical Center * Ability to read VAS Scores * Specific procedures include, but are not limited to: * Laparoscopic hysterectomy, for uterus 250 g or less * Laparoscopic hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s) * Laparoscopic hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s), with repair of enterocele * Laparoscopic hysterectomy, for uterus 250 g or less; with repair of enterocele * Laparoscopic hysterectomy, for uterus greater than 250 g * Laparoscopic hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s) * Laparoscopic hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s), with repair of enterocele * Laparoscopic hysterectomy, for uterus greater than 250 g; with repair of enterocele

Exclusion criteria

* History of chronic pelvic pain * Abdominal surgery * History of psychiatric disease * Currently taking analgesic medications * Currently taking sedatives * Liver disease * Renal disease with CrCl \< 60cc/min. * History of burns from application of ice. * Women who did not consent for the study. * Intraoperative concern for increased blood loss * Unable to speak English * Unable to understand VAS Scores * Undergoing concomitant abdominal procedures. * Allergy to motrin, toradol, Percocet, Tylenol * Active or history of peptic ulcer disease * History of GI bleeding or perforation * Hemorrhagic diathesis * Severe uncontrolled heart failure * Inflammatory bowel disease

Design outcomes

Primary

MeasureTime frameDescription
POD1 Visual Analog Pain (VAS) ScoreMorning of post operative day 1 (~24 hours after surgery)Visual Analog Scores (VAS) Scores in the morning of post op day 1 (\ 24 hours after surgery) The scale is from 0 to 10 (0=no pain and 10=being worst pain ever)

Secondary

MeasureTime frameDescription
POD1 Quality of Recovery ScorePostoperative Day 1QoR-40 is a quality of recovery 40-item questionnaire based on how the patient has felt in the past 24 hours. It provides a global score and sub scores across five dimensions: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It is a measure of postoperative quality of recovery in a range of clinical and research situations.
1st 24hr Total Dose of NarcoticTotal narcotic use from intra-op to 24 hours post-opTotal amount of narcotic in morphine equivalents administered to patients who were admitted for overnight extended recovery and/or observation. This includes narcotics given intra-operatively, in the post-anesthesia care unit and during their inpatient stay up until 24 hours postop.
Length of StayPost-operative Day 1Length of hospital stay measured in the number of nights spent at the hospital. Subjects were given the option for same-day discharge home from the PACU or overnight inpatient observation.
POD4 VAS ScoresVAS Scores at 4 days post-surgery.Visual Analog Scores 4 days post-surgery. VAS pain score of 0 to a score of worst pain indicating a score of 10 (0=no pain and 10=being worst pain ever)
POD4 Satisfaction ScoreData collected as of postoperative day 4Patient's satisfaction with their pain management as of postoperative day 4, rated on a scale of 1 - 10, where 1 is very dissatisfied and 10 is very satisfied.
Time to First Bowel MovementUp to post op day 4Time to first bowel movement in days
Oxycodone 5mg Doses Taken Since DischargeData collected as of Postoperative day 4The number of oxycodone 5mg doses (whether as oxycodone 5mg or as percocet 5/325) taken since discharge up until postoperative 4.
POD4 Quality of RecoveryPostoperative Day 4QoR-40 is a quality of recovery 40-item questionnaire based on how the patient has felt in the past 24 hours. It provides a global score and sub scores across five dimensions: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It is a measure of postoperative quality of recovery in a range of clinical and research situations.

Other

MeasureTime frameDescription
ICE-T Arm Patients Who Requested Supplemental Narcotics in Addition to Their ICE-T RegimenUp until postoperative day 4Enrolled patients were randomized at the end of surgery to 1 of 2 postoperative pain regimens: ICE-T opioid-sparing regimen or the Standard opioid-centric regimen. The pain regimen protocols began upon PACU discharge. Subjects received their regimens as assigned, except that patients assigned to the ICE-T opioid-sparing group who requested additional narcotic medications prior to postoperative day 4 were prescribed supplemental opioids in addition to their ICE-T regimen medications.

Countries

United States

Participant flow

Recruitment details

Prior to surgery, patients will be asked to participate in the study in their private patient rooms or in medical clinic.

Pre-assignment details

111 patients were assessed for eligibility, but 45 were excluded (30 did not meet inclusion criteria, and 15 declined to participate). Therefore, 66 patients were randomized.

Participants by arm

ArmCount
ICE-T
Toradol and Tylenol were given as pain management post-operative of total laparoscopic hysterectomy
36
Standard of Care (Control)
Received routine pain management postoperative of laparoscopic hysterectomy
30
Total66

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up22
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicICE-TStandard of Care (Control)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
36 Participants30 Participants66 Participants
Body Mass Index31.0 kg/m^229.8 kg/m^230.8 kg/m^2
Charlson Comorbidity Index0 Index0 Index0 Index
Current Smoker7 Participants9 Participants16 Participants
Depression/Anxiety1 Participants1 Participants2 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants0 Participants4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
32 Participants30 Participants62 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants1 Participants3 Participants
Race (NIH/OMB)
Black or African American
19 Participants18 Participants37 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants0 Participants4 Participants
Race (NIH/OMB)
White
11 Participants11 Participants22 Participants
Sex: Female, Male
Female
36 Participants30 Participants66 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
STOP-BANG Score1.0 scores on a scale1.0 scores on a scale1.0 scores on a scale

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 360 / 30
other
Total, other adverse events
7 / 363 / 30
serious
Total, serious adverse events
0 / 360 / 30

Outcome results

Primary

POD1 Visual Analog Pain (VAS) Score

Visual Analog Scores (VAS) Scores in the morning of post op day 1 (\ 24 hours after surgery) The scale is from 0 to 10 (0=no pain and 10=being worst pain ever)

Time frame: Morning of post operative day 1 (~24 hours after surgery)

Population: This population are participants that are approximately 24 hours post Total Laparoscopic Hysterectomy procedure. 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up).

ArmMeasureValue (MEDIAN)
ICE-T Opioid Sparing RegimenPOD1 Visual Analog Pain (VAS) Score5.8 Score on a scale
STANDARD Postoperative RegimenPOD1 Visual Analog Pain (VAS) Score5 Score on a scale
p-value: 0.16Wilcoxon (Mann-Whitney)
Secondary

1st 24hr Total Dose of Narcotic

Total amount of narcotic in morphine equivalents administered to patients who were admitted for overnight extended recovery and/or observation. This includes narcotics given intra-operatively, in the post-anesthesia care unit and during their inpatient stay up until 24 hours postop.

Time frame: Total narcotic use from intra-op to 24 hours post-op

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The postoperative day 1 analysis outcomes included n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up. The subjects who chose same-day discharge were excluded from the analysis of total narcotic use within 24 hours post-op due to differences in reporting and access to medications. The analysis of this variable included n=27 ICE-T arm and n=23 Standard arm.

ArmMeasureValue (MEDIAN)
ICE-T Opioid Sparing Regimen1st 24hr Total Dose of Narcotic77 oral morphine milligram equivalents
STANDARD Postoperative Regimen1st 24hr Total Dose of Narcotic111.5 oral morphine milligram equivalents
p-value: 0.01Wilcoxon (Mann-Whitney)
Secondary

Length of Stay

Length of hospital stay measured in the number of nights spent at the hospital. Subjects were given the option for same-day discharge home from the PACU or overnight inpatient observation.

Time frame: Post-operative Day 1

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up).

ArmMeasureValue (MEDIAN)
ICE-T Opioid Sparing RegimenLength of Stay1 nights
STANDARD Postoperative RegimenLength of Stay1 nights
p-value: 1Wilcoxon (Mann-Whitney)
Secondary

Oxycodone 5mg Doses Taken Since Discharge

The number of oxycodone 5mg doses (whether as oxycodone 5mg or as percocet 5/325) taken since discharge up until postoperative 4.

Time frame: Data collected as of Postoperative day 4

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

ArmMeasureValue (MEDIAN)
ICE-T Opioid Sparing RegimenOxycodone 5mg Doses Taken Since Discharge0 Doses
STANDARD Postoperative RegimenOxycodone 5mg Doses Taken Since Discharge7.0 Doses
p-value: <0.001Wilcoxon (Mann-Whitney)
Secondary

POD1 Quality of Recovery Score

QoR-40 is a quality of recovery 40-item questionnaire based on how the patient has felt in the past 24 hours. It provides a global score and sub scores across five dimensions: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It is a measure of postoperative quality of recovery in a range of clinical and research situations.

Time frame: Postoperative Day 1

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 1 outcomes included 60 subjects (n= 32 ICE-T arm POD1 analysis, 1 withdrew, 3 loss to follow up; n=28 Standard care arm POD1 analysis, 2 loss to follow up).

ArmMeasureValue (MEDIAN)
ICE-T Opioid Sparing RegimenPOD1 Quality of Recovery Score161.5 Score on a scale
STANDARD Postoperative RegimenPOD1 Quality of Recovery Score162.5 Score on a scale
p-value: 1Wilcoxon (Mann-Whitney)
Secondary

POD4 Quality of Recovery

QoR-40 is a quality of recovery 40-item questionnaire based on how the patient has felt in the past 24 hours. It provides a global score and sub scores across five dimensions: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale. QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It is a measure of postoperative quality of recovery in a range of clinical and research situations.

Time frame: Postoperative Day 4

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

ArmMeasureValue (MEDIAN)
ICE-T Opioid Sparing RegimenPOD4 Quality of Recovery179.5 Score on a scale
STANDARD Postoperative RegimenPOD4 Quality of Recovery177.0 Score on a scale
p-value: 0.47Wilcoxon (Mann-Whitney)
Secondary

POD4 Satisfaction Score

Patient's satisfaction with their pain management as of postoperative day 4, rated on a scale of 1 - 10, where 1 is very dissatisfied and 10 is very satisfied.

Time frame: Data collected as of postoperative day 4

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

ArmMeasureValue (MEDIAN)
ICE-T Opioid Sparing RegimenPOD4 Satisfaction Score10.0 Score on a scale
STANDARD Postoperative RegimenPOD4 Satisfaction Score8.0 Score on a scale
p-value: 0.4Wilcoxon (Mann-Whitney)
Secondary

POD4 VAS Scores

Visual Analog Scores 4 days post-surgery. VAS pain score of 0 to a score of worst pain indicating a score of 10 (0=no pain and 10=being worst pain ever)

Time frame: VAS Scores at 4 days post-surgery.

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

ArmMeasureValue (MEDIAN)
ICE-T Opioid Sparing RegimenPOD4 VAS Scores3 Score on a scale
STANDARD Postoperative RegimenPOD4 VAS Scores4 Score on a scale
p-value: 0.58Wilcoxon (Mann-Whitney)
Secondary

Time to First Bowel Movement

Time to first bowel movement in days

Time frame: Up to post op day 4

Population: Patients that have undergone procedure were observed to see when they had their first bowel movement post-operation up to 4 days. 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

ArmMeasureValue (MEDIAN)
ICE-T Opioid Sparing RegimenTime to First Bowel Movement2 days
STANDARD Postoperative RegimenTime to First Bowel Movement3 days
p-value: 0.02Wilcoxon (Mann-Whitney)
Other Pre-specified

ICE-T Arm Patients Who Requested Supplemental Narcotics in Addition to Their ICE-T Regimen

Enrolled patients were randomized at the end of surgery to 1 of 2 postoperative pain regimens: ICE-T opioid-sparing regimen or the Standard opioid-centric regimen. The pain regimen protocols began upon PACU discharge. Subjects received their regimens as assigned, except that patients assigned to the ICE-T opioid-sparing group who requested additional narcotic medications prior to postoperative day 4 were prescribed supplemental opioids in addition to their ICE-T regimen medications.

Time frame: Up until postoperative day 4

Population: 66 participants were enrolled (36 ICE-T arm; 30 Standard Care arm). The final analysis for postoperative day 4 outcomes included 52 subjects (n=29 ICE-T arm POD4 analysis, 1 withdrew, 6 loss to follow up; n=23 Standard arm POD4 analysis, 7 loss to follow up).

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ICE-T Opioid Sparing RegimenICE-T Arm Patients Who Requested Supplemental Narcotics in Addition to Their ICE-T Regimen8 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026